Discover how Near-Infrared Photoimmunotherapy (NIR-PIT) is transforming precision oncology. In this video, we break down the science behind this innovative cancer treatment platform, including how it selectively destroys tumor cells and boosts immune response.
We also explore clinical trials, real-world evidence from Japan, and its market access strategy—including pricing, reimbursement, and expansion into HER2+ breast cancer, lung, and GI cancers.
What you’ll learn:
How NIR-PIT works and its dual mechanism of action
Clinical and regulatory milestones for ASP-1929 (RM-1929)
Real-world evidence from Japan’s first commercial use
Strategic insights into market segmentation and adoption
Key innovators like Rakuten Medical, Sony, and Canon Medical
Commercial opportunity estimates through 2030
???? This is a must-watch for biotech investors, oncology researchers, market access leaders, and medtech entrepreneurs.
#CancerTreatment #OncologyInnovation #NIRPIT #Immunotherapy #PrecisionMedicine #BiotechInvesting #MedicalBreakthrough #Photoimmunotherapy #RakutenMedical #MarketAccess #OncologyBusiness #MedTech #TargetedTherapy #ClinicalTrials
We also explore clinical trials, real-world evidence from Japan, and its market access strategy—including pricing, reimbursement, and expansion into HER2+ breast cancer, lung, and GI cancers.
What you’ll learn:
How NIR-PIT works and its dual mechanism of action
Clinical and regulatory milestones for ASP-1929 (RM-1929)
Real-world evidence from Japan’s first commercial use
Strategic insights into market segmentation and adoption
Key innovators like Rakuten Medical, Sony, and Canon Medical
Commercial opportunity estimates through 2030
???? This is a must-watch for biotech investors, oncology researchers, market access leaders, and medtech entrepreneurs.
#CancerTreatment #OncologyInnovation #NIRPIT #Immunotherapy #PrecisionMedicine #BiotechInvesting #MedicalBreakthrough #Photoimmunotherapy #RakutenMedical #MarketAccess #OncologyBusiness #MedTech #TargetedTherapy #ClinicalTrials
- Category
- Oncology

Be the first to comment